Aliya Lakhani
Research Subjects
Aliya Lakhani has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Junyoung O. Park
Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, USA
4 shared publications Laurence C. Chen
Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, USA
2 shared publicationsMobina Khericha
Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, USA
2 shared publicationsXimin Chen
Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, USA
2 shared publications- Yvonne Y. Chen
Molecular Biology Institute, University of California, Los Angeles, Los Angeles, USA
2 shared publications Da Hyun Kang
Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea
1 shared publication
Latest Publications
- 24 April 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (6) , 1143-1160
Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation
Metabolism is an indispensable part of T cell proliferation, activation and exhaustion, yet the metabolism of chimeric antigen receptor (CAR)-T cells remains incompletely understood. CARs are composed of extracellular domains—often single-chain variable fragments (scFvs)—that determine ligand specificity and intracellular domains that trigger signalling following antigen binding. Here, we show that CARs differing only in the scFv variously reprogramme T cell metabolism. Even without exposure to antigens, some CARs increase proliferation and nutrient uptake in T cells. Using stable isotope tracers and mass spectrometry, we observed basal metabolic fluxes through glycolysis doubling and amino acid uptake overtaking anaplerosis in CAR-T cells harbouring a rituximab scFv, unlike other similar anti-CD20 scFvs. Disparate rituximab and 14G2a-based anti-GD2 CAR-T cells are similarly hypermetabolic and channel excess nutrients to nitrogen overflow metabolism. Modest overflow metabolism of CAR-T cells and metabolic compatibility between cancer cells and CAR-T cells are identified as features of efficacious CAR-T cell therapy.
- 24 April 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (6) , 1143-1160
Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation
Metabolism is an indispensable part of T cell proliferation, activation and exhaustion, yet the metabolism of chimeric antigen receptor (CAR)-T cells remains incompletely understood. CARs are composed of extracellular domains—often single-chain variable fragments (scFvs)—that determine ligand specificity and intracellular domains that trigger signalling following antigen binding. Here, we show that CARs differing only in the scFv variously reprogramme T cell metabolism. Even without exposure to antigens, some CARs increase proliferation and nutrient uptake in T cells. Using stable isotope tracers and mass spectrometry, we observed basal metabolic fluxes through glycolysis doubling and amino acid uptake overtaking anaplerosis in CAR-T cells harbouring a rituximab scFv, unlike other similar anti-CD20 scFvs. Disparate rituximab and 14G2a-based anti-GD2 CAR-T cells are similarly hypermetabolic and channel excess nutrients to nitrogen overflow metabolism. Modest overflow metabolism of CAR-T cells and metabolic compatibility between cancer cells and CAR-T cells are identified as features of efficacious CAR-T cell therapy.
- Open Access
- 31 December 2023
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 38 (6) , 619-630
Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
Metabolism is a dynamic network of biochemical reactions that support systemic homeostasis amidst changing nutritional, environmental, and physical activity factors. The circulatory system facilitates metabolite exchange among organs, while the endocrine system finely tunes metabolism through hormone release. Endocrine disorders like obesity, diabetes, and Cushing’s syndrome disrupt this balance, contributing to systemic inflammation and global health burdens. They accompany metabolic changes on multiple levels from molecular interactions to individual organs to the whole body. Understanding how metabolic fluxes relate to endocrine disorders illuminates the underlying dysregulation. Cancer is increasingly considered a systemic disorder because it not only affects cells in localized tumors but also the whole body, especially in metastasis. In tumorigenesis, cancer-specific mutations and nutrient availability in the tumor microenvironment reprogram cellular metabolism to meet increased energy and biosynthesis needs. Cancer cachexia results in metabolic changes to other organs like muscle, adipose tissue, and liver. This review explores the interplay between the endocrine system and systems-level metabolism in health and disease. We highlight metabolic fluxes in conditions like obesity, diabetes, Cushing’s syndrome, and cancers. Recent advances in metabolomics, fluxomics, and systems biology promise new insights into dynamic metabolism, offering potential biomarkers, therapeutic targets, and personalized medicine.
- 31 December 2023
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 38 (6) , 619-630
Open AccessToward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
Metabolism is a dynamic network of biochemical reactions that support systemic homeostasis amidst changing nutritional, environmental, and physical activity factors. The circulatory system facilitates metabolite exchange among organs, while the endocrine system finely tunes metabolism through hormone release. Endocrine disorders like obesity, diabetes, and Cushing’s syndrome disrupt this balance, contributing to systemic inflammation and global health burdens. They accompany metabolic changes on multiple levels from molecular interactions to individual organs to the whole body. Understanding how metabolic fluxes relate to endocrine disorders illuminates the underlying dysregulation. Cancer is increasingly considered a systemic disorder because it not only affects cells in localized tumors but also the whole body, especially in metastasis. In tumorigenesis, cancer-specific mutations and nutrient availability in the tumor microenvironment reprogram cellular metabolism to meet increased energy and biosynthesis needs. Cancer cachexia results in metabolic changes to other organs like muscle, adipose tissue, and liver. This review explores the interplay between the endocrine system and systems-level metabolism in health and disease. We highlight metabolic fluxes in conditions like obesity, diabetes, Cushing’s syndrome, and cancers. Recent advances in metabolomics, fluxomics, and systems biology promise new insights into dynamic metabolism, offering potential biomarkers, therapeutic targets, and personalized medicine.
- Open Access
Accurate and rapid determination of metabolic flux by deep learning of isotope patterns
All life forms operate metabolism in constant flux. Metabolic fluxes offer a direct readout of cellular state, detailing the rates and driving forces of metabolic pathways. However, indirect, iterative solvers for mapping isotope patterns from tracing experiments onto metabolic fluxes leave much of cellular state uncharted. Here, we streamline metabolic flux quantitation by innovating a machine learning framework, ML-Flux, that deciphers complex isotope labeling patterns. We train neural networks using isotope pattern-flux pairs across central carbon metabolism from 26 key 13 C-glucose, 2 H-glucose, and 13 C-glutamine tracers. ML-Flux takes variable-size isotope labeling patterns as input, imputes missing isotope patterns, and outputs mass-balanced metabolic fluxes. Computation of fluxes using ML-Flux is more accurate and faster than that of leading metabolic flux analysis software employing a least-squares method. Our biochemical networks and machine learning models constitute a curated and growing online knowledgebase of metabolic flux and free energy to democratize quantitative metabolic profiling.
Open AccessAccurate and rapid determination of metabolic flux by deep learning of isotope patterns
All life forms operate metabolism in constant flux. Metabolic fluxes offer a direct readout of cellular state, detailing the rates and driving forces of metabolic pathways. However, indirect, iterative solvers for mapping isotope patterns from tracing experiments onto metabolic fluxes leave much of cellular state uncharted. Here, we streamline metabolic flux quantitation by innovating a machine learning framework, ML-Flux, that deciphers complex isotope labeling patterns. We train neural networks using isotope pattern-flux pairs across central carbon metabolism from 26 key 13 C-glucose, 2 H-glucose, and 13 C-glutamine tracers. ML-Flux takes variable-size isotope labeling patterns as input, imputes missing isotope patterns, and outputs mass-balanced metabolic fluxes. Computation of fluxes using ML-Flux is more accurate and faster than that of leading metabolic flux analysis software employing a least-squares method. Our biochemical networks and machine learning models constitute a curated and growing online knowledgebase of metabolic flux and free energy to democratize quantitative metabolic profiling.
- Open Access
Extracellular Domains of CAR Reprogram T-Cell Metabolism Without Antigen Stimulation
Metabolism is an indispensable part of T-cell proliferation, activation, and exhaustion, yet the metabolism of chimeric antigen receptor (CAR)-T cells remains incompletely understood. CARs are comprised of extracellular domains that determine cancer specificity, often using single-chain variable fragments (scFvs), and intracellular domains that trigger signaling upon antigen binding. Here we show that CARs differing only in the scFv reprogram T-cell metabolism differently. Even in the absence of antigens, some CARs increase proliferation and nutrient uptake in T cells. Using stable isotope tracers and mass spectrometry, we observe basal metabolic fluxes through glycolysis doubling and amino acid uptake overtaking anaplerosis in CAR-T cells harboring rituximab scFv, unlike other similar anti-CD20 scFvs. Disparate rituximab and 14g2a-based anti-GD2 CAR-T cells are similarly hypermetabolic and channel excess nutrients to nitrogen overflow metabolism. Since CAR-dependent metabolic reprogramming alters cellular energetics, nutrient utilization, and proliferation, metabolic profiling should be an integral part of CAR-T cell development.
Open AccessExtracellular Domains of CAR Reprogram T-Cell Metabolism Without Antigen Stimulation
Metabolism is an indispensable part of T-cell proliferation, activation, and exhaustion, yet the metabolism of chimeric antigen receptor (CAR)-T cells remains incompletely understood. CARs are comprised of extracellular domains that determine cancer specificity, often using single-chain variable fragments (scFvs), and intracellular domains that trigger signaling upon antigen binding. Here we show that CARs differing only in the scFv reprogram T-cell metabolism differently. Even in the absence of antigens, some CARs increase proliferation and nutrient uptake in T cells. Using stable isotope tracers and mass spectrometry, we observe basal metabolic fluxes through glycolysis doubling and amino acid uptake overtaking anaplerosis in CAR-T cells harboring rituximab scFv, unlike other similar anti-CD20 scFvs. Disparate rituximab and 14g2a-based anti-GD2 CAR-T cells are similarly hypermetabolic and channel excess nutrients to nitrogen overflow metabolism. Since CAR-dependent metabolic reprogramming alters cellular energetics, nutrient utilization, and proliferation, metabolic profiling should be an integral part of CAR-T cell development.